1. Home
  2. MXCT vs CURR Comparison

MXCT vs CURR Comparison

Compare MXCT & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • CURR
  • Stock Information
  • Founded
  • MXCT 1999
  • CURR 2013
  • Country
  • MXCT United States
  • CURR Singapore
  • Employees
  • MXCT N/A
  • CURR N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CURR Business Services
  • Sector
  • MXCT Health Care
  • CURR Consumer Discretionary
  • Exchange
  • MXCT Nasdaq
  • CURR Nasdaq
  • Market Cap
  • MXCT 148.2M
  • CURR 151.4M
  • IPO Year
  • MXCT 2021
  • CURR N/A
  • Fundamental
  • Price
  • MXCT $1.45
  • CURR $1.60
  • Analyst Decision
  • MXCT Buy
  • CURR Strong Buy
  • Analyst Count
  • MXCT 4
  • CURR 1
  • Target Price
  • MXCT $7.50
  • CURR $3.50
  • AVG Volume (30 Days)
  • MXCT 797.5K
  • CURR 162.0K
  • Earning Date
  • MXCT 11-05-2025
  • CURR 08-04-2025
  • Dividend Yield
  • MXCT N/A
  • CURR N/A
  • EPS Growth
  • MXCT N/A
  • CURR N/A
  • EPS
  • MXCT N/A
  • CURR N/A
  • Revenue
  • MXCT $35,754,000.00
  • CURR $41,092,419.00
  • Revenue This Year
  • MXCT N/A
  • CURR N/A
  • Revenue Next Year
  • MXCT $14.79
  • CURR $14.56
  • P/E Ratio
  • MXCT N/A
  • CURR N/A
  • Revenue Growth
  • MXCT N/A
  • CURR N/A
  • 52 Week Low
  • MXCT $1.26
  • CURR $0.33
  • 52 Week High
  • MXCT $5.20
  • CURR $7.08
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 43.25
  • CURR 45.35
  • Support Level
  • MXCT $1.39
  • CURR $1.42
  • Resistance Level
  • MXCT $1.49
  • CURR $1.71
  • Average True Range (ATR)
  • MXCT 0.06
  • CURR 0.13
  • MACD
  • MXCT 0.04
  • CURR -0.02
  • Stochastic Oscillator
  • MXCT 76.47
  • CURR 46.05

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

Share on Social Networks: